Thursday, October 22, 2020
Home Clinical Data Management

Clinical Data Management

How to resolve reference ranges issue in RAVE eDC- CRA, CRC and DM prospective.

Whether you are a Clinical Research Associate (CRA), Clinical Research Coordinator (CRC) or a Clinical Data Manager (CDM), you all face...

What is the difference between the Central lab and local lab in clinical research?

Before understanding the difference between central lab and local lab, let's understand about "why lab tests are conducted"

Parts of a clinical trial protocol and Clinical Data Management (CDM) prospective to review

This blog talks about Protocol parts and key information needed for any Data Manager to design CRF. Protocols are quite specific to...

When to Start and Stop collecting Adverse Events

When to start and when to stop? Before answering this question, let’s understand where the confusion relies. Generally we...

ECOG Performance Status

ECOG Performance Status-scale was developed by Eastern Cooperative Oncology Group. Now this group is a part of ECOG-ACRIN Cancer Research Group.This scale...

Important data points in Protocol for CRFs Creation (CDM Prospective):

Reading of whole protocol is quite important and indispensable act but by keeping following points in mind, one can read protocol with...

Parts of a clinical trial protocol and Clinical Data Management (CDM) prospective to review

This blog talks about Protocol parts and key information needed for any Data Manager to design CRF. Protocols are quite specific to studies but...

Most Read

AZ’s Tagrisso scores priority review from FDA with EGFR-mutated lung cancer

October 20, 2020: "AstraZeneca’s Tagrisso (osimertinib) has received acceptance for its supplemental New Drug Application (sNDA) and has also been granted Priority Review in...

Forxiga recommended for approval in the EU by CHMP for heart failure

October 19, 2020: "AstraZeneca’s Forxiga (dapagliflozin) has been recommended for an indication extension of its marketing authorisation in the European Union (EU) for the...

AstraZeneca advances leadership in renal disease at ASN Kidney Week 2020 Reimagined

October 20, 2020: AstraZeneca will present 84 abstracts, including 12 oral presentations and three late-breaking abstracts, across its industry-leading renal portfolio which...

AbbVie’s VENCLEXTA® Receives FDA Approval for Acute Myeloid Leukemia

October 16, 2020: "AbbVie announced that the U.S. Food and Drug Administration (FDA) has provided full approval to VENCLEXTA® (venetoclax) in combination...